ストックスクリーナーアプリを入手
1.44
0.70%
0.01
アフターアワーズ：
1.44
前日終値:
$1.43
開ける：
$1.51
24時間の取引高:
1.64M
Relative Volume:
1.16
時価総額：
$356.61M
収益：
-
当期純損益:
$-208.38M
株価収益率:
-1.20
EPS:
-1.2
ネットキャッシュフロー:
$-156.57M
1週間 パフォーマンス:
+7.46%
1か月 パフォーマンス:
-15.29%
6か月 パフォーマンス:
-68.14%
1年 パフォーマンス:
-68.14%
1日の値動き範囲:
$1.41
$1.5299
1週間の範囲:
$1.32
$1.5299
52週間の値動き範囲:
$1.105
$5.00
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
AUTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.44 | 356.61M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-18 | アップグレード | Goldman | Neutral → Buy |
| 2024-11-15 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-03-27 | 再開されました | Wells Fargo | Overweight |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2021-06-14 | アップグレード | Jefferies | Hold → Buy |
| 2021-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | JP Morgan | Overweight |
| 2020-07-22 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2019-09-23 | 開始されました | Needham | Buy |
| 2019-05-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-24 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Autolus Therapeutics Plc Adr (AUTL) 最新ニュース
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire Inc.
Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India
Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa
Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India
Autolus reports progress in commercial launch and financials - Investing.com India
Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa
Autolus at Leerink’s Global Healthcare Conference: Strategic Moves in CAR T Therapy - Investing.com
10 Best UK Growth Stocks to Buy Now - Insider Monkey
Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex
It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
Lowe’s Cos., Inc Inc. (LOW) Price Performance: The Role of Supply and Demand - The InvestChronicle
Avinger Inc [AVGR] Records 50-Day SMA of $0.7054 - Knox Daily
Floor & Decor Holdings Inc [FND] Shares Rise 0.52 % on Thursday - Knox Daily
GS Shares Experience Surge in Value - Knox Daily
Crown Holdings, Inc [CCK] Shares Fall Approximately -1.11% Over the Year - Knox Daily
VRDN Stock Sees Decline of Approximately -7.82% in Last Five Days - Knox Daily
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Enovis Corp (ENOV) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
You might want to take a look at Autolus Therapeutics plc ADR (AUTL) now - SETE News
Clean Energy Fuels Corp (CLNE)’s stock rises to 3.45 per share - US Post News
Adc Therapeutics SA (ADCT) stock analysis: A comprehensive overview - US Post News
GH Research PLC (GHRS) stock: A year of ups and downs - US Post News
Calumet Inc (CLMT)’s stock price range in the last year - US Post News
A closer look at Autolus Therapeutics plc ADR (AUTL)’s stock price trends - US Post News
Quarterly Snapshot: Quick and Current Ratios for Autolus Therapeutics plc ADR (AUTL) - The Dwinnex
Balance Sheet Insights: Edison International (EIX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Selling Your Standard Lithium Ltd (AMEX: SLI) Stock? Here’s What You Need To Know - Stocks Register
Autolus presents new data on CAR-T therapy cost benefits - Investing.com
Autolus' AUCATZYL Shows Superior Cost-Effectiveness and 84% Deep Remission Rate in Latest Data - StockTitan
A Stock Analysis Of Autolus Therapeutics plc ADR’s (AUTL) - Stocks Register
MicroAlgo Inc’s (MLGO) -2.91% Drop Is A Reason To Reconsider. - Stocks Register
Aspen Aerogels Inc (ASPN) Strikes $14.34: The Risk Seems Worthwhile At This Price - Stocks Register
Autolus reports high response in leukemia study - Investing.com India
CommScope Holding Company Inc (COMM) Is A Good Investment At Current Valuations - Stocks Register
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocks Register
These Numbers Prove Just How Vibrant The Ocugen Inc (NASDAQ: OCGN) Stock Has Been - Stocks Register
Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Barchart
FDA approves new CAR-T competitor to Gilead’s Tecartus - BioPharma Dive
Does MP Materials Corporation (NYSE: MP) Still Need To Convince Analysts? - Stocks Register
Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register
Autolus Therapeutics Plc Adr (AUTL) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):